Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSThe American Society of Health-System Pharmacists (ASHP) and Utah Drug Information Service report that the United States faces record high drug shortages in 2024, exceeding the peak a decade ago. Essential medications, including cancer treatments, anesthetics, pain medications, as well as drugs for weight loss and diabetes, are among those currently in short supply.
These shortages stem from a complex interplay of factors beyond just manufacturing quality. Economic pressures, outsourcing practices, regulatory hurdles, data integrity issues and outdated technology all contribute to the problem.
Financial constraints greatly contribute to the drug shortage problem. As drugs go off patent, and profit margins erode, quality assurance emerges as a greater concern. Congruently, suppliers and manufacturers may elect not to make the product as there stands little financial benefit to its production. Specifically, the greater the constraints around the quality of a product, whether related to the supplier or the active pharmaceutical ingredient, the tighter the margin. As manufacturers opt out of producing certain products, further downstream effects are felt as production decreases.
Outsourcing the final production of a drug can significantly impact the supply chain. The greater the distance between the source and the finished product, the higher the risk of quality issues. Monitoring product quality and ensuring timely delivery are easier with advanced technology, however, addressing problems remotely can be challenging.
Another concern is the prevalence of outdated or disparate technology used throughout the pharmaceutical supply chain. Rapid technological advancements render some investments obsolete, limiting production capacity. Even repairing certain equipment as it becomes damaged is simply not feasible. These financial constraints create a situation where tight margins lead to compromised quality.
Regulatory bodies have made substantial efforts to mitigate drug shortages by developing stricter material and product quality guidelines. The FDA’s enforcement, in theory, is meant to amend shortages. However, when audits reveal noncompliance, some manufacturers opt, out of an abundance of caution, to pause production. While this is a precautionary step, it can further hinder drug availability. To address this, the FDA has enacted a new initiative to enhance communication between investigators, manufacturers and drug shortage and compliance teams. This latest program aims to minimize production pauses for at risk shortages and allow approved operations to continue.
So, how do pharmaceutical industry stakeholders prepare and prevent these factors that contribute to drug shortages? This can be accomplished by leveraging technology and software to better identify trends and indications of pending drug shortages. For example, the ability to identify trends of late delivery or short quantities, continual nonconformance of delivery of raw ingredients or materials and active pharmaceutical ingredients all signal emerging shortage concerns.
IQVIA's SmartSolve platform incorporates supplier management processes to identify trends in on-time delivery performance and predict potential disruptions due to expanding lead times, late deliveries or shortage quantities. This foresight empowers manufacturers to plan and adapt accordingly. SmartSolve highlights the importance of supply chain visibility and identifying issues before products even arrive at the manufacturer.
The rigor within the quality management system plays a role in addressing emerging manufacturing issues. Quality assurance examines deliveries and factors in expanding lead time, late deliveries and shortage quantities to better forecast and predict shortages ahead of time. By proactively warning the market and preparing for shortages, the industry can effectively mitigate factors contributing to drug shortages.
If you are interested in learning more about the IQVIA SmartSolve platform and our Quality Compliance consulting services, visit our site here.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
From manufacturing oversight to regulatory requirements, manage quality across your organization with a single enterprise software solution.
Connected, integrated, compliant. Build, scale, and optimize your quality and regulatory workflows with SmartSolve®, IQVIA's transformative Enterprise Quality Management System, built for Life Sciences.
